| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Alessandro Dinoto, Elia Sechi, Eoin P Flanagan, Sergio Ferrari, Paolo Solla, Sara Mariotto, John J Che. Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease. Frontiers in neurology. vol 13. 2022-04-11. PMID:35401423. |
serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease. |
2022-04-11 |
2023-08-13 |
Not clear |
| Liang Wang, Hongmei Tan, Wenjuan Huang, Xuechun Chang, Jingzi ZhangBao, Lei Zhou, Chuanzhen Lu, Min Wang, Jiahong Lu, Chongbo Zhao, Chao Qua. Late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies. European journal of neurology. vol 29. issue 4. 2022-04-04. PMID:34967093. |
late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies. |
2022-04-04 |
2023-08-16 |
Not clear |
| Yunjie Li, Xia Liu, Jingxuan Wang, Chao Pan, Zhouping Tan. Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD). Frontiers in aging neuroscience. vol 14. 2022-04-04. PMID:35370624. |
myelin oligodendrocyte glycoprotein-igg-associated disorder (mogad) is a nervous system (ns) demyelination disease and a newly recognized distinct disease complicated with various diseases or symptoms; however, mogad was once considered a subset of neuromyelitis optica spectrum disorder (nmosd). |
2022-04-04 |
2023-08-13 |
Not clear |
| Vyanka Redenbaugh, Eoin P Flanaga. Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2022-03-10. PMID:35267170. |
aquaporin-4 (aqp4)-igg seropositive neuromyelitis optica spectrum disorders (aqp4-igg seropositive nmosd) and myelin oligodendrocyte glycoprotein (mog)-igg-associated disease (mogad) are inflammatory demyelinating disorders distinct from each other and from multiple sclerosis (ms).while anti-cd20 treatments can be used to treat ms and aqp4-igg seropositive nmosd, some ms medications are ineffective or could exacerbate aqp4-igg seropositive nmosd including beta-interferons, natalizumab, and fingolimod. |
2022-03-10 |
2023-08-13 |
Not clear |
| Sedat Sen, Asli Tuncer, Serkan Ozakbas, Cihat Uzunkopru, Cavid Baba, Serkan Demir, Yesim Beckmann, Haluk Gumus, Gokhan Arslan, Ahmet Kasim Kilic, Ayse Altintas, Nur Yuceyar, Omer Faruk Turan, Melih Tutuncu, Murat Terzi, Pinar Acar, Sena Destan Bunul, Belgin Petek Balci, Levent Sinan Bir, Mesrure Koseoglu, Semra Mungan, Tuncay Gunduz, Ipek Gungor Dogan, Dilcan Kotan, Ugur Uygunoglu, Ozgul Ekmekci, Meltem Demirkiran, Ozden Kamisli, Sibel Canbaz Kabay, Yusuf Tamam, Sami Omerhoca, Serhan Sevim, Sibel Guler, Murat Kurtuncu, Husnu Efendi, Rana Karabudak, Aksel Siv. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course? Multiple sclerosis and related disorders. vol 58. 2022-02-26. PMID:35216782. |
the course and outcomes of covid-19 during neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disorders (mogad) are not clearly known. |
2022-02-26 |
2023-08-13 |
Not clear |
| Masoud Etemadifar, Mehri Salari, Mohammad Reza Etemadifar, Fatemeh Sabeti, Sepand Tehrani Fateh, Zahra Aminzad. Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS. Multiple sclerosis and related disorders. vol 60. 2022-02-26. PMID:35219242. |
centrally-located transverse myelitis would facilitate the differentiation of nmosd and mog-ad from ms. differentiating neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mog-ad) from multiple sclerosis (ms) is important since ms therapies might result in progression and relapse of the former diseases. |
2022-02-26 |
2023-08-13 |
Not clear |
| Meltem Yıldız Kayaoğlu, Gözde Girgin, Ismail Solmaz, Terken Baydar, Banu Anla. Urine neopterin in childhood acute demyelinating diseases: Potential for differential diagnosis. Multiple sclerosis and related disorders. vol 59. 2022-02-12. PMID:35149394. |
inflammatory demyelinating diseases of the central nervous system (cns) in childhood include clinically and radiologically defined diseases such as acute disseminated encephalomyelitis (adem), multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disorder (mogad). |
2022-02-12 |
2023-08-13 |
Not clear |
| Laura Petrikowski, Sabrina Reinehr, Steffen Haupeltshofer, Leonie Deppe, Florian Graz, Ingo Kleiter, H Burkhard Dick, Ralf Gold, Simon Faissner, Stephanie C Joachi. Progressive Retinal and Optic Nerve Damage in a Mouse Model of Spontaneous Opticospinal Encephalomyelitis. Frontiers in immunology. vol 12. 2022-02-10. PMID:35140707. |
neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein-antibody-associated disease (mogad) are antibody mediated cns disorders mostly affecting the optic nerve and spinal cord with potential severe impact on the visual pathway. |
2022-02-10 |
2023-08-13 |
mouse |
| Simon J Hickman, Axel Petzol. Update on Optic Neuritis: An International View. Neuro-ophthalmology (Aeolus Press). vol 46. issue 1. 2022-01-31. PMID:35095131. |
more recently, the importance of optic neuritis in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein (mog) antibody disease has become more appreciated. |
2022-01-31 |
2023-08-13 |
Not clear |
| Martin W Hümmert, Louisa M Schöppe, Judith Bellmann-Strobl, Nadja Siebert, Friedemann Paul, Ankelien Duchow, Hannah Pellkofer, Tania Kümpfel, Joachim Havla, Sven Jarius, Brigitte Wildemann, Achim Berthele, Florian Then Bergh, Marc Pawlitzki, Luisa Klotz, Ingo Kleiter, Martin Stangel, Stefan Gingele, Martin S Weber, Juergen H Faiss, Refik Pul, Annette Walter, Uwe Zettl, Makbule Senel, Jan-Patrick Stellmann, Vivien Häußler, Kerstin Hellwig, Ilya Ayzenberg, Orhan Aktas, Marius Ringelstein, Olivia Schreiber-Katz, Corinna Trebs. Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCE Neurology. 2022-01-27. PMID:35082170. |
costs and health-related quality of life in patients with nmo spectrum disorders and mog-antibody-associated disease: chance objectiveto evaluate costs and health-related quality of life (hrqol) of neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein-antibody associated disease (mogad).methodsin this multicenter cross-sectional study, data on consumption of medical and non-medical resources and work ability were assessed via patient questionnaires. |
2022-01-27 |
2023-08-13 |
Not clear |
| B Rodríguez-Acevedo, A Rovira, A Vidal-Jordana, D Moncho, D Pareto, J Sastre-Garrig. [Optic neuritis: aetiopathogenesis, diagnosis, prognosis and management]. Revista de neurologia. vol 74. issue 3. 2022-01-27. PMID:35084734. |
the main causes of optic neuritis (on) are multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease, also known as mogad. |
2022-01-27 |
2023-08-13 |
Not clear |
| Gaurav Nepal, Sanjeev Kharel, Megan Ariel Coghlan, Parash Rayamajhi, Rajeev Ojh. Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis. Journal of neuroimmunology. vol 364. 2022-01-22. PMID:35063726. |
myelin oligodendrocyte glycoprotein immunoglobulin g (mog-igg)-associated disorders (mogad) is neuroimmunological disorder manifesting as episodes of adem, optic neuritis, transverse myelitis, brainstem encephalitis, and other cns manifestations and notably, distinct from multiple sclerosis (ms) and neuromyelitis optica spectrum disorders (nmosd). |
2022-01-22 |
2023-08-13 |
Not clear |
| Stephanie Barnes, Yuyi You, Ting Shen, Todd A Hardy, Clare Fraser, Stephen W Reddel, Fabienne Brilot, Sudarshini Ramanathan, Alexandr Klistorner, Con Yiannika. Structural and functional markers of optic nerve damage in myelin oligodendrocyte glycoprotein antibody-associated optic neuritis. Multiple sclerosis journal - experimental, translational and clinical. vol 7. issue 4. 2022-01-17. PMID:35035987. |
optic neuritis (on) occurs in immune-mediated disorders including multiple sclerosis (ms), aquaporin-4 antibody-positive (aqp4) neuromyelitis optica spectrum disorder (aqp4-nmosd) and myelin oligodendrocyte glycoprotein (mog) antibody-associated demyelination (mogad). |
2022-01-17 |
2023-08-13 |
Not clear |
| Jana Remlinger, Adrian Madarasz, Kirsten Guse, Robert Hoepner, Maud Bagnoud, Ivo Meli, Moritz Feil, Mathias Abegg, Christopher Linington, Anthony Shock, Babak Boroojerdi, Peter Kiessling, Bryan Smith, Volker Enzmann, Andrew Chan, Anke Salme. Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis. Neurology(R) neuroimmunology & neuroinflammation. vol 9. issue 2. 2022-01-14. PMID:35027475. |
myelin oligodendrocyte glycoprotein antibody-associated disorder (mogad) is a rare, autoimmune demyelinating cns disorder, distinct from multiple sclerosis and neuromyelitis optica spectrum disorder. |
2022-01-14 |
2023-08-13 |
Not clear |
| Jennifer S Graves, Frederike Cosima Oertel, Anneke Van der Walt, Sara Collorone, Elias S Sotirchos, Gorm Pihl-Jensen, Philipp Albrecht, E Ann Yeh, Shiv Saidha, Jette Frederiksen, Scott Douglas Newsome, Friedemann Pau. Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders. Neurology(R) neuroimmunology & neuroinflammation. vol 9. issue 2. 2021-12-27. PMID:34955459. |
visual outcomes allow tracking of neuroaxonal injury and aid in distinguishing ms from diseases such as neuromyelitis optica spectrum disorder (nmosd) or myelin oligodendrocyte glycoprotein antibody-associated diseases (mogad). |
2021-12-27 |
2023-08-13 |
Not clear |
| Selvakumar Ambika, Santhakumar Durgapriyadarshini, Krishnakumar Padmalakshmi, Veena Noronha, Deepak Arjunda. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica. Indian journal of ophthalmology. vol 70. issue 1. 2021-12-23. PMID:34937238. |
clinical profile, imaging features and short term visual outcomes of indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica. |
2021-12-23 |
2023-08-13 |
Not clear |
| Dejan Jakimovski, Samreen Awan, Svetlana P Eckert, Osman Farooq, Bianca Weinstock-Guttma. Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment. CNS drugs. 2021-12-23. PMID:34940954. |
before treatment initiation, a careful differential diagnosis and exclusion of other similar acquired demyelinating syndromes such as anti-aquaporin-4-associated neuromyelitis optica spectrum disorder (aqp4-nmosd) and myelin oligodendrocyte glycoprotein antibody spectrum disorder (mogsd) is warranted. |
2021-12-23 |
2023-08-13 |
Not clear |
| Samantha Epstein, Zongqi Xia, Annie J Lee, Megan Dahl, Keith Edwards, Elle Levit, Erin E Longbrake, Christopher Perrone, Katelyn Kavak, Bianca Weinstock-Guttman, Fatoumata Diallo, Adelle Ricci, Claire S Riley, Philip L De Jager, Rebecca Farber, Sarah F Wesle. Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data. Multiple sclerosis and related disorders. vol 57. 2021-12-19. PMID:34923427. |
this has led to significant vaccine hesitancy in patients with neuroinflammatory diseases (nid); including, but not limited to: multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), neurosarcoidosis and myelin oligodendrocyte antibody-mediated disease (mog-ad). |
2021-12-19 |
2023-08-13 |
Not clear |
| Anagha Aneesh, Alice Liu, Heather E Moss, Douglas Feinstein, Sriram Ravindran, Biji Mathew, Steven Rot. Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles. Stem cell research & therapy. vol 12. issue 1. 2021-12-11. PMID:34863294. |
optic neuritis (on) is frequently encountered in multiple sclerosis, neuromyelitis optica spectrum disorder, anti-myelin oligodendrocyte glycoprotein associated disease, and other systemic autoimmune disorders. |
2021-12-11 |
2023-08-13 |
Not clear |
| Valentina Camera, Leah Holm-Mercer, Ali Asgar Hatim Ali, Silvia Messina, Timotej Horvat, Wilhelm Kuker, Maria Isabel Leite, Jacqueline Palac. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder. JAMA network open. vol 4. issue 12. 2021-12-09. PMID:34878547. |
frequency of new silent mri lesions in myelin oligodendrocyte glycoprotein antibody disease and aquaporin-4 antibody neuromyelitis optica spectrum disorder. |
2021-12-09 |
2023-08-13 |
Not clear |